REG - Crism Therapeutics - Director Dealing
03/06/2024 15:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240603:nRSC9176Qa&default-theme=true
RNS Number : 9176Q Crism Therapeutics Corporation 03 June 2024
3 June 2024
CRISM Therapeutics Corporation
(AIM:CRTX)
Director Dealing
CRISM Therapeutics Corporation ("CRISM" or the "Company") announces that it
has been notified that Non-Executive Director, Gerald Beaney has purchased
25,000 ordinary shares of the Company at a price of 9.265 pence per share.
Following this purchase, Mr Beaney holds 25,000 ordinary shares, which
represents approximately 0.08% of the Company's total issued share capital of
32,678,312.
Enquiries:
Company Nomad and Broker Financial PR
CRISM Therapeutics Corporation S.P. Angel Corporate Finance LLP Buchanan
Andrew Webb, CEO Richard Morrison
Chris McConville, CSO Adam Cowl Mark Court mark.court@buchanancomms.co.uk
Jamie Hooper jamie.hooper@buchanancomms.co.uk
via Buchanan +44 (0) 20 3470 0470 +44 (0) 20 7466 5000
Dealings by Persons Discharging Managerial Responsibilities
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Gerald Beaney
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name CRISM Therapeutics Corporation
b) LEI 213800XFW6MKVCHHPW88
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares with no par value
Identification code ISIN: VGG042401262
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)
Director/PDMR Price Volume
Gerald Beaney 9.265 25,000
d) Aggregated information
- Aggregated volume 25,000
- Price £2,316.25
e) Date of the transaction 3 June 2024
f) Place of the transaction Outside a trading venue
d)
Aggregated information
- Aggregated volume
25,000
- Price
£2,316.25
e)
Date of the transaction
3 June 2024
f)
Place of the transaction
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFFSRSIVIIS